Here, a systematic gene expression analysis using clinical patient data in the TCGA database revealed that GPCs undergo general alterations in cancer where GPC1 and GPC2 exhibit significantly higher expression levels in primary solid tumors whereas GPC3, GPC5 and GPC6 display an overall lower expression levels compared to normal tissues. The gene discussed is GPC5; the disease is cancer.